Skip to content

Clinical trials

Hypercholesterolemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: France Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20051
20083
20091
20111
201211
201310
20143
20155
20162
20172
20181
20201
20214
20224
20233
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Active, not recruiting5
Terminated4
Recruiting3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen13
Sanofi12
Novartis Pharmaceuticals5
Regeneron Pharmaceuticals5
Lescuyer Laboratory3
Merck Sharp & Dohme LLC3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Valbiotis3
Institut Pasteur de Lille2
AB Biotics, SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia64
Dyslipidemias13
Hyperlipidemias11
Cardiovascular Diseases7
Atherosclerosis6
Hyperlipoproteinemia Type II6
Coronary Artery Disease4
Homozygous Familial Hypercholesterolemia3
Arteriosclerosis2
HIV Infections2

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.